Jump to content

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation (Q69922732)

From Wikidata

scientific article published on 01 June 1988

Language	Label	Description	Also known as
default for all languages	No label defined
English	Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation	scientific article published on 01 June 1988

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

based on heuristic

inferred from title

publication date

1 June 1988

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

0 references

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

57

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

608-611

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Measurement of oestradiol receptors by five institutions on common tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

British interlaboratory quality assessment of steroid receptor assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunocytochemical demonstration of estrogen receptors by monoclonal antibodies in human breast cancer: correlation with estrogen receptor assay by dextran-coated charcoal method.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triphenylethylenes: a new class of protein kinase C inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2900647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1988.138

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2900647%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69922732&oldid=2222606875"